The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man
- 1 November 1991
- journal article
- clinical trial
- Published by Wiley in Clinical Endocrinology
- Vol. 35 (5) , 423-430
- https://doi.org/10.1111/j.1365-2265.1991.tb03560.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Nausea and vasopressinThe Lancet, 1991
- UNIX: The Minimal ManualAmerican Journal of Psychiatry, 1990
- Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the ratEuropean Journal of Pharmacology, 1985
- Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal bloodBrain Research, 1983
- The effect of serotonin agonist 1-(trifluoromethylphenly)-piperazine on corticotropin releasing factor and arginine vasopressin in rat hypothalamic nuclei.Endocrinologia Japonica, 1982
- VASOPRESSIN IN AFFECTIVE ILLNESSThe Lancet, 1978
- An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the ratJournal of Comparative Neurology, 1978
- "Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?Science, 1976
- Central cholinergic and adrenergic mechanisms in the release of antidiuretic hormoneBritish Journal of Pharmacology, 1972
- Pituitary Serotonin Content: Effects of Melatonin or Deprivation of WaterScience, 1970